Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Novo Nordisk A/S
David C W Lau; Lars Erichsen; Ann Marie Francisco; Altynai Satylganova; Carel W le Roux; Barbara McGowan; Sue D Pedersen; Kirsi H Pietiläinen; Domenica Rubino; Rachel L Batterham